Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AstraZeneca’s COPD treatment Bevespi Aerosphere fails in phase IIIb trial
Image: AstraZeneca’ Bevespi Aerosphere has failed to show superiority against umeclidinium/vilanterol in phase IIIb trial. Photo: courtesy of AstraZeneca.
Image: AstraZeneca’ Bevespi Aerosphere has failed to show superiority against umeclidinium/vilanterol in phase IIIb trial. Photo: courtesy of AstraZeneca.